Notice ID: d197a191fe4f455c4fa080ea2cd60170Special Notice
DATA SERVICES
Archived on July 31, 2015. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 7:00 PM UTC+02:00
- Posted
- July 1, 2015
- Notice type
- Special Notice
- NAICS
- 541990: All Other Professional, Scientific, and Technical Services
- Agency
- Department of CommerceUS CENSUS BUREAU
Notice details
- Office
- DEPT OF COMMERCE CENSUS
- Place of performance
- 4600 SILVER HILL ROAD, Suitland, 20746
- PSC
- R: SUPPORT SVCS (PROF, ADMIN, MGMT)
- Last updated
- Dec 5, 2025
Identifiers
- Solicitation number
- 15-00870RT
- Notice ID
- d197a191fe4f455c4fa080ea2cd60170
Description
UNDER THE AUTHORITY OF THE FEDERAL ACQUISITION REGULATION, PART 6, SUBPARTS 6.301 AND 6.302, THE U.S. CENSUS BUREAU INTENDS TO CONTRACT WITH NATIONAL MOTOR FREIGHT TRAFFIC ASSOCIATION, INC. (NMFTA), ON A SOLE SOURCE BASIS, TO PROVIDE A QUATERLY FTP FILE OF STANDARD CARRIER ALPHA CODE (SCAC) OF 89,855 REGISTERED COMPANIES TO FUNCTION AS PART OF THE AESDIRECT SYSTEM. THE TRADE COMMUNITY USES THE SCAC TO IDENTIFY TRANSPORTATION COMPANIES WHEN ELECTRONIC EXPORT INFORMATION (EEI) IS REPORTED IN AESDIRECT. THE CODES ARE PROVIDED FOR ALL COMPANIES THAT REPORT VIA VESSEL, RAIL AND TRUCK MODES OF TRANSPORTATION. THE PERIOD OF PERFORMANCE FOR THE FOLLOWING SERVICES WILL BE SEPTEMBER 25, 2015 THROUGH SEPTEMBER 24, 2016. ANY RESPONSE TO THIS NOTICE MUST SHOW CLEAR AND CONVINCING EVIDENCE, THAT COMPETITION WOULD BE ADVANTAGEOUS TO THE GOVERNMENT. IN DOING SO, INTERESTED SOURCES MUST SUBMIT PRICING AND OTHER INFORMATION THAT DEMONSTRATES THEIR ABILITY TO MEET THE CENSUS BUREAU'S NEEDS. DETAILED CAPABILITY STATEMENTS MUST BE SUBMITTED TO RHONDA TALBERT VIA EMAIL ADDRESS rhonda.m.talbert@census.gov. THIS NOTICE IS NOT TO BE CONSIDERED A REQUEST FOR QUOTATIONS OR PROPOSALS. NO CONTRACT WILL BE AWARDED ON THE BASIS OF OFFERS RECEIVED IN RESPONSE TO THIS NOTICE, BUT OFFERS WILL BE USED TO DETERMINE IF A COMPARABLE SOURCES IS AVAILABLE AND MORE ADVANTAGEOUS TO THE GOVERNMENT. IF NO AFFIRMATIVE WRITTEN RESPONSE IS RECEIVED WITHIN 15 DAYS FROM THE PUBLICATION OF THIS SYNOPSIS, A CONTRACT MAY BE ISSUED TO THE NATIONAL MOTOR FREIGHT TRAFFIC ASSOCIATION, WITHOUT FURTHER NOTICE.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Rhonda M. Talbert
Documents
No documents available.
Lifecycle
Solicitation:
15-00870RTSimilar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
The National Archives and Records Administration seeks a Project Coordinator to support the activities of a project team guiding a 3-year initiative to undertake multiple conservation projects at NARA’s Presidential Libraries and Museums. Work willbe performed in accordance with the attached statement of work. Amendment 0001 - Update RFQ Documentation Amendment 0002 - Update and Replace Previous RFQ to include the following changes: --Updated CLIN Structure --Updated Evaluation Structure -- Update Terms & Conditions -- Removal of Ambiguous Language -- Remove BPA References Amendment 0003 - Revised Submission Due date to allow time for Government response to contractor questions (attach Questions and revised RFQ) | - | Solicitation | 11/19/2026 |
This is not a solicitation announcement. This is a Sources Sought Notice (SSN) only. This SSN is issued solely for market research and planning purposes – it does not constitute a Request for Proposal (RFP) or a promise to issue an RFP in the future. Further, the SSN does not commit the Government to contract for any supply or service whatsoever. The FDA is not seeking proposals and will not accept any unsolicited proposals. Responders are advised that the U.S. Government will not pay for any information or administrative costs incurred in response to this SSN; all costs associated with responding to this SSN will be solely at the expense of the interested respondents. Not responding to this SSN does not preclude participation in any future RFP, if issued. The purpose of this sources sought synopsis is to gain knowledge of potential qualified vendors to include potential 8(a) vendors 8(a) relative to the North American Industry Classification System (NAICS) code and capable of providing multidisciplinary scientific and regulatory professional services in support of FDA Centers and Offices. Responses to this Sources Sought Notice will be used by the Government to make appropriate determinations about potential sources. Project Title: FDA Scientific and Regulatory Support Services (SRS) IDIQ Background/Overview: The Food and Drug Administration (FDA) is a science-based regulatory agency critically important to the stability of the nation's public health and health care systems. FDA protects and promotes the health and safety of all Americans by enhancing the availability of safe medical products, foods, and animal products, and by promoting innovation that addresses unmet medical and public health needs. FDA decisions must be based on the best available scientific data and employ the best tools and methods available to ensure products meet the highest quality standards, while fostering innovation in the products it regulates. In support of its regulatory mission, FDA conducts scientific research across a broad range of disciplines including vaccines, drug safety, food safety, medical devices, biologics, toxicology, radiological products, and more. FDA's science is increasingly data-centric, complex, and collaborative, involving multidisciplinary groups across its Centers and Offices. Within the Center for Drug Evaluation and Research (CDER), the Office of Computational Science (OCS), established under the Office of Translational Sciences, supports the data management, technical, and analytic needs of the regulatory review process. OCS manages and supports analytical tools, data standards, and computing infrastructure that form the backbone of modern regulatory review for medical products. Purpose: The FDA is seeking information from experienced sources in Scientific and Regulatory Support Services as it is contemplating the establishment of a Indefinite Delivery Indefinite Quantity (IDIQ) to such services. The FDA’s primary objective for this effect is to obtain Contractor services related to scientific and regulatory support across a broad range of mission requirements. Depending on the requirement, services may support scientific research, regulatory review, clinical and non-clinical analyses, epidemiology and surveillance, scientific data interpretation, laboratory activities, technical writing, training, and scientific program coordination. Objectives: The objective of the contemplated SRS acquisition is to provide FDA with responsive, high-quality scientific and regulatory support across a broad range of mission requirements. Depending on the task order, services may support scientific research, regulatory review, clinical and nonclinical analyses, epidemiology and surveillance, scientific data interpretation, laboratory activities, technical writing, training, and scientific program coordination. The Government is interested in sources capable of providing the scientific depth and operational capacity needed to: Conduct scientifically sound analyses and prepare defensible, traceable technical products supporting FDA review and public-health decisions. Provide qualified personnel across multiple scientific and regulatory disciplines, including specialized and emerging areas. Support clinical and nonclinical study-data review, standardized scientific datasets, statistical computing, data fitness, quality assessment, and interpretation. Respond to multiple simultaneous task orders, changing priorities, time-sensitive scientific questions, and evolving requirements across FDA organizations. Maintain scientific quality, data integrity, documentation, confidentiality, and continuity of performance. Deliver effective scientific training, technical writing, knowledge transfer, and program-management support tied directly to scientific and regulatory missions. Project Requirements: The following descriptions are illustrative of the types of services that may be ordered. They are provided to inform industry responses and do not establish final task-order requirements. Each task order would define its own objectives, tasks, deliverables, performance expectations, staffing qualifications, and period of performance. Scientific Research and Regulatory Review Support: Support scientific investigations, literature and evidence reviews, research planning, study design, methodological assessments, scientific consultations, and technical analyses relevant to FDA-regulated products. Prepare scientific assessments, briefing materials, review support documentation, and other products that allow Government scientists and reviewers to evaluate scientific evidence and communicate findings. Provide subject-matter expertise to address complex or emerging regulatory science questions. Clinical and Nonclinical Study-Data Review and Analysis: Support the scientific review of clinical and nonclinical datasets submitted for regulatory purposes, including data fitness and completeness assessments, exploratory safety analyses, descriptive and inferential statistical analyses, and preparation of tables, listings, figures, and visualizations. Subject-matter expertise in applicable clinical and nonclinical study-data standards, including CDISC SDTM, ADaM, and SEND, is particularly relevant to these services. The RRS BPA describes review-oriented services that assess study data and produce analyses for FDA reviewers; SRS would focus on the scientific and analytical performance of those services rather than maintenance of the underlying software platforms. Epidemiology, Biostatistics, Pharmacovigilance, and Surveillance: Conduct epidemiological and Pharmacoepidemiological research, biostatistical analyses, pharmacovigilance assessments, signal detection and evaluation, public-health surveillance, and interpretation of real-world data and evidence as required by individual scientific programs. Activities may include protocol and analysis-plan support, assessment of study limitations and bias, statistical programming, results interpretation, and technical reporting. Scientific Data Standards, Quality, and Analytics: Provide scientific expertise related to data standards, controlled terminology, study-data interpretation, data quality and fitness, and reproducible analytical methods. Support scientific data preparation and validation, biostatistics, bioinformatics, computational science, and other specialized analyses when the primary deliverable is scientific or regulatory in nature. Distinguish these activities from enterprise database administration, application development, platform engineering, and IT operations. Laboratory and Specialized Scientific Support: Provide laboratory-related scientific and technical expertise, research assistance, analytical method support, study coordination, quality documentation, and interpretation or reporting of laboratory findings where required by a task order. Respondents should identify the specific laboratory disciplines, facilities, qualifications, and methods they can support rather than assume that all clinical trial operations or laboratory testing will be included. Scientific Writing, Training, Knowledge Management, and Communications: Develop scientific reports, regulatory review support materials, technical summaries, study documentation, research publications, presentations, training curricula, and knowledge-transfer materials. Provide specialized scientific and regulatory training, including instruction related to study-data standards and analytical methods. Communications and knowledge-management work should be directly connected to scientific or regulatory activities rather than general enterprise communications or IT support. Scientific Program and Project Management: Plan and coordinate scientific studies and projects; manage milestones, deliverables, schedules, staffing, and technical reporting; facilitate multidisciplinary collaboration; track performance and quality; and support continuity during transitions. Such activities must be integral to scientific and regulatory service delivery, not standalone enterprise IT project management. Scope Distinctions: The contemplated SRS acquisition is not intended to replace vehicles for enterprise IT architecture, systems or application development, cloud or data-platform operations, infrastructure administration, software maintenance, generalized service-desk support, or other predominantly IT functions. Where a task combines scientific analysis and enabling technology, the Government will determine the appropriate vehicle and scope based on the primary purpose of the requirement. The final boundary between SRS and remaining RRS or other vehicles is subject to FDA and OAGS confirmation. Capabilities and Technical Experience: Interested small businesses should submit a concise capability statement demonstrating relevant, actual performance and capacity to satisfy the contemplated requirements. Responses should clearly distinguish capabilities performed by the respondent from those provided by subcontractors, affiliates, or proposed teaming partners. FDA is particularly interested in the following: Relevant Experience: Describe comparable scientific and regulatory engagements, customer organizations, contract or order identifiers where releasable, approximate value, period of performance, work performed, disciplines supported, and measurable outcomes. Explain how the experience relates to the breadth and complexity of the contemplated SRS work. Scientific and Regulatory Disciplines: Describe the service areas the respondent can perform, with concrete examples involving scientific research, regulatory analysis, clinical and nonclinical datasets, statistical methods, epidemiology, laboratory work, scientific writing, and training as applicable. Do not claim disciplines for which experience cannot be substantiated. Workforce and Concurrent Delivery Capacity: Describe the organization's demonstrated ability to recruit, retain, and deploy highly specialized scientific and regulatory professionals across a broad range of disciplines, including individuals with advanced degrees, niche technical expertise, and experience supporting complex scientific and regulatory programs. FDA recognizes that certain highly specialized skill sets may require recruitment from an international talent pool, including individuals holding or requiring employment-based visa sponsorship (e.g., H-1B) or other appropriate work authorization. Respondents should describe their experience recruiting and retaining such personnel, managing applicable sponsorship and work authorization requirements, and mitigating potential staffing disruptions during contract transitions. Responses should also address the organization's ability to fill hard-to-recruit positions, maintain continuity of specialized expertise, accommodate surge requirements, and support multiple concurrent task orders. Where available, provide representative workforce metrics, such as available staffing capacity, average time-to-fill for specialized positions, and retention or attrition trends. Include a representative example demonstrating the organization's ability to respond to surge requirements or manage concurrent scientific and regulatory assignments, including its approach to staffing continuity, resource allocation, and timely delivery. Scientific Quality and Data Practices: Describe scientific quality-control procedures, independent review, data integrity and reproducibility practices, use of applicable scientific standards, confidentiality controls, and experience handling sensitive regulatory or research information. Representative Complex Requirement: Describe one or more specific scientific or regulatory assignments presenting substantial technical complexity, urgent timelines, multidisciplinary coordination, or simultaneous delivery requirements. Explain the challenge, approach, expertise, staffing considerations, deliverables, and outcomes. AI, Emerging Technology, and Responsible Use: Describe the organization's experience applying artificial intelligence (AI), machine learning (ML), or other emerging technologies to scientific research, regulatory review, or related analytical activities, as applicable. Provide representative examples of these applications and describe the organization's approaches to validating outputs, maintaining scientific integrity, ensuring appropriate human oversight, and managing associated risks. Identify any experience implementing responsible AI practices or governance frameworks, particularly in federal or regulated environments. Teaming and Prime-Contractor Role: Describe anticipated prime, subcontracting, joint-venture, or teaming arrangements and the work each participant would perform. Explain how the prime would exercise management and technical oversight while meeting applicable small-business requirements. Contract Structure Feedback: Identify whether the firm could support the full breadth of contemplated services or a defined subset and explain why. Instructions for Responses: Your responses to the questions provided below will assist the Government in selecting the appropriate acquisition method. Page limit: Maximum 15 pages (font size Times New Roman 11 or larger). A copy of the company capability statement will also be accepted (but not in place of the responses to the below questions). The anticipated period of performance is a 5-year ordering period. After review of the responses received, a pre-solicitation synopsis and formal solicitation may be published on SAM.gov. In addition to responses to the below questions, each vendor responding to this SSN shall also fill out and provide responses to “Attachment B-Vendor Feedback Form.” The Vendor Feedback Form is not included in the 15-page limit. A copy of the company capability statement will also be accepted (but not in place of the responses to the below questions or the Vendor Feedback Form). Responses to this notice must include company name, address, point of contact, size of business pursuant to the NAICS code, and must respond to the following questions: Is your business a small business under the NAICS code? Is your firm certified under Section 8(a) of the Small Business Act? Included is a draft Statement of Work that is inclusive of the anticipated Task Areas (Attachment A). All interested parties can provide written opinions on the draft Statement of Work. All opinions expressed should focus on strengthening the draft Statement of Work Tasks to ensure industry understands and comprehends the government’s requirements. Business Status Provide the legal business name and address Primary point of contact and the contact information SAM.gov Unique Entity Identifier (UEI) CAGE code Proposed NAICS code and size status Applicable small-business socioeconomic designations (including 8(a), HUBZone, service-disabled veteran-owned, veteran-owned, women-owned, or small disadvantaged business, as applicable) Identify whether the respondent proposes to participate as prime contractor, joint venture, or subcontractor Responses to this notice shall be submitted via e-mail to Amanda Edger, Contract Specialist, at Amanda.Edger@fda.hhs.gov (with a CC: to Ian Weiss, Contracting Officer, at Ian.Weiss@fda.hhs.gov), by November 23, 2026, at 2:00 pm EST. After a review of the received responses, a pre-solicitation synopsis and formal solicitation may be published on SAM.gov. No solicitation is currently available. This is not a request for proposals and in no way obligates the Government to award any contract. Responses to this Sources Sought Notice will not be considered adequate responses to the solicitation, a request to be added to a prospective offerors list, or a request to receive a copy of the solicitation. Ref. No. FDA-RFI-75F40127R00007/ALP No. OMITS-2027-136942. | - | Market Research | 11/23/2026 |
This Commercial Solutions Opening (CSO) solicitation is issued in accordance with R-DFARS 212.70, Defense Commercial Solutions Opening NAICS Code and Associated Description: 541990 - All Other Professional, Scientific, and Technical Services Federal Agency Name and Contracting Officer Address: FA7014 - Air Force District of Washington, Secretary of the Air Force Enterprise Contracting Division (AFDW/PKS)AFDW/PKS is soliciting White Papers from interested offerors under this Two-Step CSO. The Department of the Air Force (DAF) seeks innovative commercial-service solutions to enhance acquisition and program management support capabilities through artificial intelligence (AI), automation, data interoperability, workflow improvements, and analytical efficiencies. The Government is particularly interested in solutions that improve the effectiveness and efficiency of existing mission-support functions, including acquisition processes, Defense Industrial Base analysis, information technology integration, and Modernized Process Model (MPM) capabilities. First Step: WHITE PAPER DUE DATE AND TIME: White Papers will be accepted until Friday, 20 November 2026 at 12:00 PM ET. White Papers may be submitted at any time during this period. White Papers received after specified date and time, will be considered late in accordance with FAR 52.212-1(f).Second Step: PROPOSAL DUE DATE AND TIME: To be provided in the Requests for Proposal sent to offerors that submit White Papers considered to be of further interest to the Air Force. Proposals received after specified date and time, will be considered late in accordance with 52.212-1(f).White Papers shall be submitted through the Solicitation Module of the PIEE at https://piee.eb.mil via the Solicitations offer tab NLT 20 November 2026 by 12:00 P.M. EST. White Papers submitted by email or hand-carried will not be evaluated (exception for system outage, see below). For instructions on how to post an offer, please refer to the Posting Offer demo: https://pieetraining.eb.mil/wbt/sol/Posting_Offer.pdf. It is the offerors responsibility to obtain written confirmation of receipt of all electronic files of the full proposal by the contracting office. In the event the Solicitation Module is down, the alternate method for proposal submission is via email to the CS and CO. The offeror must obtain prior written approval from the CO or CS to use the alternate submission method. The Offeror shall obtain written approval from the Contracting Officer or Contracting Specialist to submit the proposal via an alternate method. The only alternative method the Government will consider is email.This posting has been amended to reflect NAICS 541990. | - | Solicitation | 11/20/2026 |
Amendment 01 The purpose of this amendment # 01 is to clarify the RFQ requirements by responding to questions submitted and also to add IT applicable clauses into the solicitation. Unless specifically noted, all other terms remain unchanged. Note: The Offeror should acknowledge on the cover page or first pages on its Quote receipt of this amendment. Please see the attached Amendment 01_SMART for more details. Title: SMART IRB Governance, Administration, and Operations Support (GAOS) This is a combined synopsis/solicitation for commercial items/services prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) FAR Subpart 13.5—Simplified Procedures for Certain Commercial Items; and FAR Part 12— Acquisition of Commercial Items; and is expected to exceed the simplified acquisition threshold. Introduction and Background Objectives The National Center for Translational Sciences (NCATS) requires a partner to facilitate user administration, process/workflow improvements, content development/moderation, requirements gathering, and dissemination of the SMART IRB (Streamlined, Multisite, Accelerated Resources for Trials Institutional Review Board) portfolio of services. SMART IRB relies on three systems: (1) the SMARTIRB.org website which is used for content distribution, notification, and educational purposes, (2) Joinder, through which institutions enter institutional information and sign the SMART IRB Authorization Agreement (AA), and (3) the Online Reliance System (ORS), through which Institutional Review Board (IRB) reliance arrangements under the SMART IRB Agreement are documented on a study-by-study basis. The selected partner will provide support in accordance with this SOW to aid in the facilitation and growth of SMART IRB. Please see the attached RFQ 75N98026Q00287 for more details | - | Combined Synopsis | 11/13/2026 |
The Naval Air Systems Command (NAVAIR), Patuxent River, MD intends to issue a modification to the existing Sustaining Engineering and Support (SES) IV Contract, N0001924C0005, on a sole source basis to Northrop Grumman Systems Corporation (NGSC). The anticipated contract modification is for incorporation of highly specialized sustainment support of the Triton MQ-4C Unmanned Aircraft Systems (UAS) unique to the Royal Australian Air Force (RAAF). Efforts will include, but not be limited to, generation of RAAF unique engineering test procedures, RAAF unique network configuration documentation, and RAAF unique engineering and technical reports, informed by currently performed sustainment activities. This contract modification is being pursued on a sole source basis under the statutory authority of 10 U.S.C. 3204 (a)(l) as implemented by Federal Acquisition Regulation (FAR) Subpart 6.103-1, "Only One Responsible Source and No Other Type of Supplies or Services will Satisfy Agency Requirements." NGSC is the sole designer, developer, manufacturer, integrator, and producer of the MQ-4C Triton air vehicles and ground stations. Therefore, NGSC is the only source with the requisite knowledge of the Triton design, operation, and maintenance to successfully provide the necessary FSRs, engineering, systems integration, and sustainment support. Unless otherwise stated herein, no formal request for proposal or additional written information is currently available. A determination by the Government not to compete is solely within the discretion of the Government. IMPORTANT ADDITIONAL INFORMATION FOR INTERESTED PARTIES: This synopsis is published for information purposes only. (THIS NOTICE IS NOT A REQUEST FOR COMPETITIVE PROPOSALS). All responsible sources may submit a capability statement, which will be considered by the agency. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Companies interested in subcontracting opportunities should contact Northrop Grumman Systems Corporation – Aerospace Systems, attention: Vicky Harper-Hall, Socio-Economic Programs Sector Manager, email: vicky.harper-hall@ngc.com or phone: (310) 331-3824. There are no commitments by the Government to issue any solicitations, make an award, or to be responsible for any monies expended by any interested parties before award of a contract for the efforts mentioned above. Information provided herein is subject to change and in no way binds the Government to solicit for or award a contract. No telephone inquiries will be accepted. | - | Pre-Solicitation | 11/25/2026 |
Additional Details
Solicitation Number
15-00870RT
Archive Date
Jul 31, 2015